To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis
NCT06061471
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
454
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Skin Diseases
Interventions
DRUG:
AK111
DRUG:
AK111
Sponsor
Akeso